Explore
Our Journey Beyond Sunset Boulevard
0 Ungluers have
Faved this Work
Login to Fave
The revival of DeltaRex-G (formerly Rexin-G)'”the first proactive tumor-hunting/tumor-killing biomedicine of this kind in history'”returned active tumor surveillance and a precision-guided 'silver bullet' (dnG1 killer gene) to the cancer clinic with 'Expanded Access' in 2019. Empowered by US Right-to-Try legislation, while honoring ethical principles of 'informed consent,' this unique graphic/picturesque presentation of clinical and translational medicine is intended for postmodern (post-Enlightenment) layman readers, including cancer patients, students, researchers, and future practitioners in the field of precision gene-based medicine. Confronting logical fallacies in popular opinion, the authors present newsworthy, up-to-date clinical research documenting the successful management of refractory metastatic cancers with tumor-targeted gene therapy vectors'”validating 'pathotropic' (disease-seeking) tumor targeting avant la lettre.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 12 times via unglue.it ebook links.
- 12 - pdf (CC BY) at Unglue.it.
Keywords
- Clinical & internal medicine
- Diseases & disorders
- medicine
- oncology
Links
DOI: 10.5772/intechopen.95307Editions